|
Volumn 16, Issue 1, 1998, Pages 189-206
|
Medication use during pregnancy for neurologic conditions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIEMETIC AGENT;
BETA1A INTERFERON;
CARBAMAZEPINE;
CODEINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DIAZEPAM;
ENOXAPARIN;
ETHOSUXIMIDE;
FIBRINOLYTIC AGENT;
FOLIC ACID;
GLATIRAMER;
HEPARIN;
INTERFERON BETA SERINE;
LOW MOLECULAR WEIGHT HEPARIN;
MAGNESIUM SULFATE;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PHENOBARBITAL;
PHENYTOIN;
TRIMETHADIONE;
UNINDEXED DRUG;
VALPROIC ACID;
VITAMIN K GROUP;
WARFARIN;
ADULT;
BLEEDING;
CLINICAL TRIAL;
DEPRESSION;
ECLAMPSIA;
EMBRYOTOXICITY;
EPILEPSY;
FEMALE;
HEADACHE;
HEART ARREST;
HUMAN;
HYPOREFLEXIA;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALFORMATION SYNDROME;
MULTIPLE SCLEROSIS;
NEUROPATHY;
NEWBORN;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PARALYSIS;
PHASE 3 CLINICAL TRIAL;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
PUERPERIUM;
REVIEW;
SEDATION;
SPONTANEOUS ABORTION;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TERATOGENICITY;
THROMBOEMBOLISM;
URINARY TRACT INFECTION;
VITAMIN K DEFICIENCY;
|
EID: 0031938979
PISSN: 07338619
EISSN: None
Source Type: Journal
DOI: 10.1016/S0733-8619(05)70374-1 Document Type: Article |
Times cited : (10)
|
References (103)
|